- 12:58 PM Cyclone Phyan to bring heavy rains to Mumbai
- 12:54 PM Cipla launches drug to treat H1N1 virus
- 12:54 PM Shree Renuka acquires Brazilian firm for $82 m...
- 12:54 PM JPMorgan bullish on Educomp, sees target at Rs 100...
- 12:48 PM Nifty trades above 4950; metal, IT, auto, pharma u...
- 12:42 PM Buy IVRCL Infra; target of Rs 382: Motilal Oswal
- 12:37 PM Allow stake in Indian carriers: Foreign airlines u...
- 12:04 PM Pathik Gandotra positive on Yes Bank
- 11:59 AM World needs to cooperate on easy policy exit: Worl...
- 11:59 AM Maradona to face FIFA hearing on Sunday
KRChoksey Research has recommended a buy rating on GlaxoSmithKline Consumer Healthcare with a 12-month target price of Rs 781 in its September 19, 2008 research report. "At the CMP of Rs 619, the stock is trading at 14.4x TTM EPS of Rs 43.0. Going forward, we believe the company is expected to see strong performance driven by leveraging its flagship brand Horlicks and aggressive plans of new launches. We initiate coverage on the stock with a Buy rating and a 12-month target price of Rs 781, implying an upside potential of 26% which is arrived by discounting CY09E EPS of Rs 52 by 15x," says KRChoksey's research report.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
To read the full report click on the attachment......
Attachments : GSK Consumer-IC-190908.pdf |
|
Stock Advice
|
|
|
Today's Special Column
with Pronab Sen
Union Ministry of Statistics and Programme Implementation , Chief Statistician and Secretary
-
Most Read
-
Most Viewed
- 10 companies that MF managers love
- 10 Companies that FIIs love
- Experts on stocks and sectors to pick/avoid now
- Mitesh Thacker's top picks for today's trade
- Ganeshaspeaks: Market prediction for Nov 11
- IPO scam: SEBI bars Pyramid Saimira for 7 years
- How greed got the better of this Morgan Stanley star
- Sensex may drift down to 12500, -ve on RIL: Shankar Sharma
- JPMorgan bullish on Educomp, sees target at Rs 1000/share
Source: CNBC-TV18
- Nifty trades above 4950; metals, IT, auto, pharma up
Source: Moneycontrol.com
- Buy IVRCL Infra; target of Rs 382: Motilal Oswal
Source: Moneycontrol.com
- Allow stake in Indian carriers: Foreign airlines urge govt
Source: Moneycontrol.com
- NMDC, AP body to enter mining pact
Source: Business Line
- Volvo-Eicher semi low-floor buses to hit the roads next yr
Source: Business Line
- Petronet likely to award LNG jetty contract next month
Source: Business Line
- NTPC units shut down on coal shortage
Source: Business Line
